Hanna Salo

Title: Innovations of Inventor Hanna Salo

Introduction

Hanna Salo is a notable inventor based in Helsinki, Finland. She has made significant contributions to the field of biotechnology, particularly in the development of conjugates involving anti-EGFR1 antibodies. With a total of three patents to her name, her work has the potential to impact medical treatments and therapies.

Latest Patents

Hanna Salo's latest patents include innovative conjugates that comprise an anti-EGFR1 antibody or an EGFR binding fragment. One of her inventions details a conjugate that includes at least one dextran derivative, which contains a D-glucopyranosyl unit. This dextran derivative is uniquely modified, with specific carbon atoms substituted by a particular substituent, allowing for a bond to be formed with the anti-EGFR1 antibody through a reaction involving aldehyde and amino groups. This inventive approach enhances the efficacy of the antibody in therapeutic applications.

Career Highlights

Throughout her career, Hanna has worked with several companies, including Tenboron Oy and Glykos Finland Oy. Her experience in these organizations has contributed to her expertise in the field of biotechnology and innovation.

Collaborations

Hanna has collaborated with notable coworkers such as Anne Kanerva and Anne Leppanen. These partnerships have likely enriched her research and development efforts.

Conclusion

Hanna Salo's contributions to biotechnology through her patents and collaborations highlight her role as an influential inventor in her field. Her work continues to pave the way for advancements in medical treatments.